New stool screening tests for colorectal cancer

Digestion

Volumn 76, Issue 1, 2007, Pages 26-33

  Young, Graeme P ^a,c   Cole, Stephen ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Colorectal neoplasia; Fecal immunochemical test; Fecal occult blood test; Guaiac based fecal occult blood test

Indexed keywords

GUAIAC;

CANCER SCREENING; COLORECTAL CANCER; DEVELOPMENT; EVALUATION; FECAL IMMUNOCHEMICAL TEST; HUMAN; INTERMETHOD COMPARISON; OCCULT BLOOD TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

COLORECTAL NEOPLASMS; FECES; GUAIAC; HUMANS; IMMUNOCHEMISTRY; INDICATORS AND REAGENTS; MASS SCREENING; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 35349014751     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000108391     Document Type: Review

References (24)

1. Young GP, Allison J: Screening for colorectal cancer; in Yamada T, Alpers D, Kaplowitz N, Laine L, Owyang C, Powell D (eds): Textbook of Gastroenterology, ed 5. Philadelphia, Lippincott, Williams and Wilkins, 2007, in press.
2. Watson JMG, Junger G: Principles and practice of screening for disease. Public Health Pap 1968;34.
3. Young GP, Macrae FA, St John DJB: Clinical methods of early detection: basis, use and evaluation; in Young GP, Rozen P, Levin B (eds): Prevention and Early Detection of Colorectal Cancer. London, Saunders, 1996, pp 241-270.
4. Osborn NK, Ahlquist DA: Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005;128:1-22.
5. Regueiro CR: AGA Future Trends Committee report: colorectal cancer: a qualitative review of emerging screening and diagnostic technologies. Gastroenterology 2005;129:1083-1103.
6. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F: Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. NEJM 1993;328:1365-1371.
7. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O: Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-1471.
8. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-1477.
9. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, Snover D, Schuman LM: The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-1607.
10. Cole SR, Young GP, Esterman A, Cadd B, Morcom J: A randomized trial of the impact of new fecal hemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10:117-122.
11. Allison JE, Tekawa IS, Ransom LJ, Adrain AL: A comparison of fecal occult blood tests for colorectal cancer screening. N Engl J Med 1996;334:155-159.
12. Young GP, St John DJB, Winawer SJ, Rozen P: Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies. Am J Gastroenterol 2002;97:2499-2507.
13. Young GP, St John DJB: Faecal occult blood tests: choice, usage and clinical applications. Clin Biochem Rev 1992;13:161-167.
14. Smith A, Young GP, Cole SR, Bampton P: Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 2006;107:2152-2159.
15. Wong BC, Wong WM, Cheung KL, Tong TS, Rozen P, Young GP, Chu KW, Ho J, Law WL, Tung HM, Lai KC, Hu WH, Chan CK, Lam SK: A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther 2003;18:941-946.
16. Young GP: Molecular approaches to stool screening for colorectal cancer. Curr Colorect Cancer Rep 2006;2:30-35.
17. Fraser CG, Matthew CM, Mowat NA, Wilson JA, Carey FA, Steele RJ: Immunochemical testing of individuals positive for guaiac faecal occult blood tests in a screening programme for colorectal cancer. Lancet Oncol 2006;7:101-103.
18. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y: A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007;146:244-255.
19. Smith A, Young G, Cole S, Morcom J, Chandler H, La Pointe L: A quantifiable fecal immunochemical test (FIT) for hemoglobin facilitates balancing sensitivity with specificity when screening for colorectal cancer. Gastroenterology 2004;126:S1346.
20. Imperiale TF, Ransohoff DF, Itzkowitz SH, Turnbull BA, Ross ME: Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 2004;351:2704-2714.
21. Woolf SH: A smarter strategy? - reflections on fecal DNA screening for colorectal cancer. N Engl J Med 2004;351:2755-2758.
22. Haug U, Hillebrand T, Bendzko P, Low M, Rothenbacher D, Stegmaier C, Brenner H: Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA. Clin Chem 2007;53:787-790.
23. Itzkowitz S, Jandorf L, Brand R, Rabeneck L, Schroy PC 3rd, Sontag S, Johnson D, Skoletsky J, Durkee K, Markowitz S, Shuber A: Improved fecal DNA test for colorectal cancer screening. Clin Gastroenterol Hepatol 2007;5:111-117.
24. O'Brien MJ, Yang S, Mack C, Xu H, Huang CS, Mulcahy E, Amorosino M, Farraye FA: Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 2006;30:1491-1501.